Suchergebnisse - "Pastore, Friederike"

PubPharm (31)

1

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

enthalten in: Leukemia research | 2023

von Haque, T. | Cadenas, F. | Xicoy, B. | +20

2

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

enthalten in: British journal of haematology | 2023

von Pastore, F. | Gittinger, H. | Raab, S. | +18

3

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Vieito, M. | Moreno, V. | Spreafico, A. | +18

4

Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation : occurrence, risk factors, relapse patterns, and outcome

enthalten in: Annals of hematology | 2023

von Fraccaroli, A. | Vogt, D. | Rothmayer, M. | +3

5

Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome

enthalten in: Annals of hematology | 2023

von Fraccaroli, A. | Vogt, D. | Rothmayer, M. | +3

6

Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome

enthalten in: Annals of hematology | 2023

von Fraccaroli, A. | Vogt, D. | Rothmayer, M. | +3

7

Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome

enthalten in: Annals of hematology | 2023

von Fraccaroli, A. | Vogt, D. | Rothmayer, M. | +3

8

Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis

enthalten in: Cancer | 2022

von Pastore, F. | Pastore, A. | Rothenberg-Thurley, M. | +12

9

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity

enthalten in: Molecular cancer therapeutics | 2021

von Brehmer, D. | Beke, L. | Wu, T. | +36

10

PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN

enthalten in: Cancer discovery | 2020

von Pastore, F. | Bhagwat, N. | Pastore, A. | +23